retinol acetate: Clinical Trials

5 completed, 1 unknown. 4 Phase 1, 1 Not applicable, 1 Phase 2.

By phase and status

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Bioefficacy of Beta-cryptoxanthin From Biofortified Maize β-cryptoxanthin - Vitamin A Deficiency	Not applicable	Unknown	Newcastle University	50	2019-04-01	2020-11-04
Evaluation of the Effects of Oral QLT091001 in Adults With Impaired Dark Adaptation QLT091001, Placebo - Impaired Dark Adaptation	Phase 2	Completed	QLT Inc.	43	2013-11-01	2015-07-14
Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65) QLT091001 - Retinitis Pigmentosa (RP)	Phase 1	Completed	QLT Inc.	5	2012-02-01	2014-12-15
Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01) QLT091001 - LCA (Leber Congenital Amaurosis), RP (Retinitis Pigmentosa)	Phase 1	Completed	QLT Inc.	27	2012-01-01	2014-07-28
Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations QLT091001 - LCA (Leber Congenital Amaurosis), RP (Retinitis Pigmentosa)	Phase 1	Completed	QLT Inc.	32	2009-11-01	2013-05-14
Safety and Tolerability of Retinoid QLT091001 in Healthy Volunteers QLT091001 - Healthy Human Volunteers	Phase 1	Completed	QLT Inc.	18	2008-09-01	2009-03-30